GBE has delivered impressive progress on its alternative olefins production technology. It is now entering the final phase of industrialisation and on the verge of commercialisation. Low oil prices make for a difficult business environment, but efforts by management to diversify away from the oil-related market could help to reduce the oil price dependence. Nevertheless, there is immediate commercial market potential for GBE. Our core valuation range is €37-56 per share.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Opening the next chapter
Global Bioenergies SA (ALGBE:PAR) | 0 0 1.6% | Mkt Cap: 77.3m
- Published:
29 Jun 2016 -
Author:
Catharina Hillenbrand-Saponar -
Pages:
12
GBE has delivered impressive progress on its alternative olefins production technology. It is now entering the final phase of industrialisation and on the verge of commercialisation. Low oil prices make for a difficult business environment, but efforts by management to diversify away from the oil-related market could help to reduce the oil price dependence. Nevertheless, there is immediate commercial market potential for GBE. Our core valuation range is €37-56 per share.